Gaurav Aggarwal, Director at HYPERION THERAPEUTICS INC (HPTX), bought 5,000 shares at $10.00 ($50K) on 2012-07-31, disclosed to the SEC on 2012-08-02.
Open-market purchase of $50k HPTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| OCRX | BUY | 2015-05-06 | $27K | — | Filing → |